These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 8498383)
1. Ratio of ST-segment and myoglobin slopes to estimate myocardial salvage during thrombolytic therapy for acute myocardial infarction. Baskin JM; Wilkins ML; Ohman EM; Clemmensen P; Grande P; Christenson RH; Sevilla DC; Wagner NB; Wagner GS Am J Cardiol; 1993 Jun; 71(15):1362-5. PubMed ID: 8498383 [No Abstract] [Full Text] [Related]
2. Rebound increase of plasminogen activator inhibitor type I after cessation of thrombolytic treatment for acute myocardial infarction is independent of type of plasminogen activator used. Genser N; Lechleitner P; Maier J; Dienstl F; Artner-Dworzak E; Puschendorf B; Mair J Clin Chem; 1998 Feb; 44(2):209-14. PubMed ID: 9474013 [TBL] [Abstract][Full Text] [Related]
3. Comparison of five cardiac markers in the detection of reperfusion after thrombolysis in acute myocardial infarction. Lavin F; Kane M; Forde A; Gannon F; Daly K Br Heart J; 1995 May; 73(5):422-7. PubMed ID: 7786656 [TBL] [Abstract][Full Text] [Related]
4. Serum myoglobin/carbonic anhydrase III ratio as a marker of reperfusion after myocardial infarction. Vuotikka P; Uusimaa P; Niemelä M; Väänänen K; Vuori J; Peuhkurinen K Int J Cardiol; 2003 Oct; 91(2-3):137-44. PubMed ID: 14559123 [TBL] [Abstract][Full Text] [Related]
6. [Myoglobin concentration in serum as an early marker of reperfusion in patients with acute myocardial infarction after thrombolytic therapy]. Kobusiak-Prokopowicz M; Mysiak A Pol Merkur Lekarski; 1997 Sep; 3(15):109-12. PubMed ID: 9461704 [TBL] [Abstract][Full Text] [Related]
7. High frequency QRS electrocardiography in the detection of reperfusion following thrombolytic therapy. Aversano T; Rudikoff B; Washington A; Traill S; Coombs V; Raqueno J Clin Cardiol; 1994 Apr; 17(4):175-82. PubMed ID: 8187367 [TBL] [Abstract][Full Text] [Related]
8. [Thrombolytic therapy of acute myocardial infarction]. Chen JL Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):69-70. PubMed ID: 15808085 [No Abstract] [Full Text] [Related]
9. [Thrombolytic therapy of acute myocardial infarction]. Chen HZ Zhonghua Nei Ke Za Zhi; 1993 Jan; 32(1):5-6. PubMed ID: 8404321 [No Abstract] [Full Text] [Related]
10. A score predicts failure of reperfusion after fibrinolytic therapy for acute myocardial infarction. French JK; Ramanathan K; Stewart JT; Gao W; Théroux P; White HD Am Heart J; 2003 Mar; 145(3):508-14. PubMed ID: 12660675 [TBL] [Abstract][Full Text] [Related]
11. Therapy of acute myocardial infarction in the 1990s. Flores ED; Lange RA; Cigarroa RG; Hillis LD Am J Med Sci; 1990 Jun; 299(6):415-24. PubMed ID: 2113353 [No Abstract] [Full Text] [Related]
12. Serum myoglobin and creatine kinase enzymes in acute myocardial infarction treated with Anistreplase. McCullough DA; Harrison PG; Forshall JM; Irving JB; Hillman RJ J Clin Pathol; 1992 May; 45(5):405-7. PubMed ID: 1597518 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of repeat thrombolytic treatment after acute myocardial infarction. White HD; Cross DB; Williams BF; Norris RM Br Heart J; 1990 Sep; 64(3):177-81. PubMed ID: 2119665 [TBL] [Abstract][Full Text] [Related]
14. [Thrombolytic therapy in acute myocardial infarction. Mechanism of action and treatment considerations]. Roguin A; Manaster J; Roguin N Harefuah; 1993 Jun; 124(12):770-5. PubMed ID: 8375772 [No Abstract] [Full Text] [Related]